The early acute phase of severe COVID‐19 has been associated with a delayed and narrow immune response,1 as well as a storm of proinflammatory cytokine responses that includes interleukin (IL)‐2, IL‐6, IL‐7, IL‐17 and tumor necrosis factor (TNF)‐α.2, 3. This evidence concerns the gene TNF and COVID-19.